Profilo
Neil M.
Cowen is the founder of Essentialis, Inc., founded in 2003, where the title held was President & Chief Scientific Officer from 2003 to 2006.
Current job includes Member-Regents Board at Concordia University-Irvine starting in 2022.
Former jobs include Principal at The Dow Chemical Co., Vice President-Strategic Development at Epicyte Pharmaceutical, Inc. from 2001 to 2003, and Senior Vice President-New Product Development at Soleno Therapeutics, Inc. Education history includes undergraduate and graduate degrees from Michigan State University, a doctorate from Iowa State University, and an MBA from the University of Indianapolis.
Posizioni attive di Neil Cowen
| Società | Posizione | Inizio |
|---|---|---|
Concordia University-Irvine
Concordia University-Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Direttore/Membro del Consiglio | 01/02/2022 |
Precedenti posizioni note di Neil Cowen
| Società | Posizione | Fine |
|---|---|---|
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Fondatore | 01/01/2006 |
Epicyte Pharmaceutical, Inc.
Epicyte Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Corporate Officer/Principal | 01/01/2003 |
| SOLENO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Formazione di Neil Cowen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Michigan State University
Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iowa State University
Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epicyte Pharmaceutical, Inc.
Epicyte Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Concordia University-Irvine
Concordia University-Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Indianapolis
University of Indianapolis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
















